Used as an intermediate in pharmaceutical synthesis, particularly in the development of kinase inhibitors for cancer treatment. Its structure supports binding to specific enzyme active sites, enhancing selectivity and potency. Also employed in medicinal chemistry research to construct complex heterocyclic systems. The tert-butyl carbamate group acts as a protecting group for amines during multi-step synthesis, allowing controlled deprotection under mild acidic conditions. Its trifluoromethyl quinoline core contributes to improved metabolic stability and lipophilicity, beneficial for drug candidate optimization.